Hyperventilation versus standard ventilation for infants in postoperative care for congenital heart defects with pulmonary hypertension

J Anesth. 2009;23(1):80-6. doi: 10.1007/s00540-008-0682-7. Epub 2009 Feb 22.

Abstract

Purpose: In infants undergoing surgery for cardiac defects with left-to-right shunt, a hyperventilation strategy has been applied to prevent pulmonary hypertensive crisis (PHC). Hyperventilation with a large tidal volume and/or higher airway pressure, however, may be detrimental to the lung. This randomized study compared the effects of hyperventilation versus standard ventilation.

Methods: We enrolled 22 infants with a preoperative pulmonary-to-systemic blood pressure ratio of more than 0.7. Hyperventilation, with a tidal volume of 10-12 ml x kg(-1) to keep Pa(CO2) between 30 and 35 mmHg, was randomly applied in 11 patients for 16 h or more. The other 11 patients were randomly assigned to standard ventilation, with a 6- to 8- ml x kg(-1) tidal volume.

Results: The peak inspiratory pressure was higher (20 +/- 3 vs 18 +/- 2 cmH2O; P = 0.018), and Pa(CO2) (34 +/- 5 vs 42 +/- 7 mmHg; P = 0.003) and positive end-expiratory pressure (3 +/- 0 vs 5 +/- 0; P < 0.0001) were significantly lower in the hyperventilation than in the standard ventilation group. The Pa(CO2)/inspiratory fraction of oxygen Pa(CO2) ratio decreased from 244 +/- 160 mmHg at the onset of postoperative ventilation, to 177 +/- 96 mmHg at 24 h (P = 0.038) in the hyperventilation group, versus a decrease from 240 +/- 89 to 220 +/- 97 mmHg in the standard ventilation group not significant (NS). Serum interleukin (IL)-6 level, measured at 24 h postoperatively, was significantly lower (P = 0.02) in the standard ventilation than in the hyperventilation group, suggesting an attenuated postoperative systemic inflammatory response. A single patient in each group developed PHC.

Conclusion: Hyperventilation may cause lung injury and systemic inflammation in infants with pulmonary hypertension undergoing corrective heart surgery.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Pressure / physiology
  • C-Reactive Protein / metabolism
  • Carbon Dioxide / blood
  • Cardiac Surgical Procedures / methods*
  • Female
  • Heart Defects, Congenital / surgery*
  • Humans
  • Hypertension, Pulmonary / surgery*
  • Hyperventilation*
  • Infant
  • Interleukin-6 / blood
  • Male
  • Oxygen / blood
  • Pilot Projects
  • Positive-Pressure Respiration
  • Postoperative Care / methods*
  • Pulmonary Circulation
  • Pulmonary Gas Exchange
  • Respiration, Artificial*
  • Treatment Outcome

Substances

  • Interleukin-6
  • Carbon Dioxide
  • C-Reactive Protein
  • Oxygen